Abstract
Our study provides the first evidence on site-specific Medicare spending on chemotherapy adjusting for patient comorbid illnesses, cancer type, and other cancer-related risks.
| Original language | English (US) |
|---|---|
| Number of pages | 1 |
| Journal | The American journal of managed care |
| Volume | 24 |
| Issue number | 10 |
| State | Published - Oct 1 2018 |